Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 2, Pages e0150197
Publisher
Public Library of Science (PLoS)
Online
2016-02-27
DOI
10.1371/journal.pone.0150197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer
- (2015) Lecia V. Sequist et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
- (2015) Pasi A. Jänne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating tumor-derived DNA is shorter than somatic DNA in plasma
- (2015) Florent Mouliere et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
- (2015) Peiyong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating free DNA as a surrogate for tumor material for EGFR and KRAS analysis
- (2015) Gillian Ellison et al. CLINICAL CANCER RESEARCH
- Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
- (2014) Britta Weber et al. BMC CANCER
- Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
- (2014) M. Qiu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Novel drugs against non-small-cell lung cancer
- (2014) Robert Pirker CURRENT OPINION IN ONCOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR
- (2013) S.E. Norton et al. CLINICAL BIOCHEMISTRY
- A New Blood Collection Device Minimizes Cellular DNA Release During Sample Storage and Shipping When Compared to a Standard Device
- (2013) Sheila E. Norton et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients
- (2013) Audrey Vallée et al. LUNG CANCER
- Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
- (2011) K. Taniguchi et al. CLINICAL CANCER RESEARCH
- Personalized medicine for lung cancer: new challenges for pathology
- (2011) Keith M Kerr HISTOPATHOLOGY
- Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
- (2010) S. Wang et al. CLINICAL CANCER RESEARCH
- The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer
- (2010) F. R. Hirsch et al. CLINICAL CANCER RESEARCH
- Detection of Mutated K-rasDNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
- (2009) Ying-Hsiu Su et al. Annals of the New York Academy of Sciences
- Detection of circulating fetal nucleic acids: a review of methods and applications
- (2009) E C W Hung et al. JOURNAL OF CLINICAL PATHOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started